| Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics D Yang, W Zhang, H Zhang, F Zhang, L Chen, L Ma, LM Larcher, S Chen, ... Theranostics 10 (8), 3684, 2020 | 627 | 2020 |
| In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies F Lipi, S Chen, M Chakravarthy, S Rakesh, RN Veedu RNA biology 13 (12), 1232-1245, 2016 | 110 | 2016 |
| Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis RNV Tao Wang*, Lanmei Chen*, Arpitha Chikkanna, Suxiang Chen, Isabell ... Theranostics 11 (11), 5174-5196, 2021 | 63 | 2021 |
| Development of DNA aptamers targeting low-molecular-weight amyloid-β peptide aggregates in vitro M Chakravarthy, H AlShamaileh, H Huang, RK Tannenberg, S Chen, ... Chemical communications 54 (36), 4593-4596, 2018 | 42 | 2018 |
| Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and d-altritol nucleic acid-modified 2′-O-methyl RNA mixmer antisense oligonucleotides for exon skipping … BT Le, S Chen, M Abramov, P Herdewijn, RN Veedu Chemical communications 52 (92), 13467-13470, 2016 | 38 | 2016 |
| Nucleic acid-based theranostics for tackling Alzheimer's Disease M Chakravarthy, S Chen, PR Dodd, RN Veedu Theranostics 7 (16), 3933, 2017 | 35 | 2017 |
| Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro S Chen, BT Le, M Chakravarthy, TR Kosbar, RN Veedu Scientific Reports 9 (1), 6078, 2019 | 33 | 2019 |
| Therapeutically significant microRNAs in primary and metastatic brain malignancies AA Balachandran, LM Larcher, S Chen, RN Veedu Cancers 12 (9), 2534, 2020 | 31 | 2020 |
| Radiolabeling of nucleic acid aptamers for highly sensitive disease-specific molecular imaging L Hassanzadeh, S Chen, RN Veedu Pharmaceuticals 11 (4), 106, 2018 | 31 | 2018 |
| A systematic investigation of key factors of nucleic acid precipitation toward optimized DNA/RNA isolation Y Li, S Chen, N Liu, L Ma, T Wang, RN Veedu, T Li, F Zhang, H Zhou, ... BioTechniques 68 (4), 191-199, 2020 | 30 | 2020 |
| Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2′-O-Methyl Mixmer Antisense Oligonucleotide S Chen, BT Le, K Rahimizadeh, K Shaikh, N Mohal, RN Veedu Molecules 21 (11), 1582, 2016 | 22 | 2016 |
| Antisense oligonucleotide-mediated splice switching: Potential therapeutic approach for cancer mitigation P Raguraman, AA Balachandran, S Chen, SD Diermeier, RN Veedu Cancers 13 (21), 5555, 2021 | 19 | 2021 |
| Antisense oligonucleotides as potential therapeutics for type 2 diabetes S Chen, N Sbuh, RN Veedu nucleic acid therapeutics 31 (1), 39-57, 2021 | 19 | 2021 |
| Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics. Theranostics. 2020; 10 (8): 3684–707 D Yang, W Zhang, H Zhang, F Zhang, L Chen, L Ma, LM Larcher, S Chen, ... Epub 2020/03/25. eng, 0 | 17 | |
| Development of Novel Chemically-Modified Nucleic Acid Molecules for Efficient Inhibition of Human MAPT Gene Expression M Chakravarthy, S Chen, T Wang, RN Veedu Genes 11 (6), 667, 2020 | 15 | 2020 |
| Cyclometalated Ru (II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway L Chen, J Wang, X Cai, S Chen, J Zhang, B Li, W Chen, X Guo, H Luo, ... Bioorganic Chemistry 119, 105516, 2022 | 11 | 2022 |
| Cyclometalated Ru (II) β-carboline complexes induce cell cycle arrest and apoptosis in human HeLa cervical cancer cells via suppressing ERK and Akt signaling J Chen, Y Deng, J Wang, S Chen, F Peng, X He, M Liu, H Luo, J Zhang, ... JBIC Journal of Biological Inorganic Chemistry 26 (7), 793-808, 2021 | 10 | 2021 |
| Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics. Theranostics 10 (8): 3684–3707 D Yang, W Zhang, H Zhang, F Zhang, L Chen, L Ma, LM Larcher, S Chen, ... Epub 2020/03/25. doi: 10.7150/thno. 41580, 2020 | 10 | 2020 |
| Progress, opportunity, and perspective on exosome isolation-Efforts for efficient exosomebased theranostics. Theranostics 10, 3684–3707 D Yang, W Zhang, H Zhang, F Zhang, L Chen, L Ma, LM Larcher, S Chen, ... | 10 | 2020 |
| Aptamer-engineered (nano) materials for theranostic applications N Rabiee, S Chen, S Ahmadi, RN Veedu Theranostics 13 (15), 5183, 2023 | 7 | 2023 |
